Autoantibodies from recovered Guillain-Barré syndrome patients exhibit altered effector functions that prevent subsequent neuron degeneration
Guillain-Barré syndrome (GBS) is an autoimmune polyneuropathy that is the leading cause of nonpoliovirus-associated acute flaccid paralysis worldwide. In most cases, GBS occurs following an infection, most commonly Campylobacter jejuni, through the induction of antibodies recognizing bacterial ganglioside-mimicking lip...